Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Adrenomedullin receptor 2 (AM2) is a heterodimeric G protein-coupled receptor formed by the association of the Calcitonin receptor-like receptor (CALCRL) and the Receptor activity-modifying protein 3 (RAMP3) [1, 2]. It serves as a primary mediator for the biological actions of adrenomedullin, a peptide hormone involved in the regulation of vascular tone and endothelial integrity [3]. Activation of the AM2 receptor triggers the Gs-adenylyl cyclase-cAMP signaling pathway, leading to potent vasodilation and the stabilization of the blood-brain and blood-lymph barriers [4, 5]. In addition to its cardiovascular roles, AM2 is essential for proper lymphatic vascular development and fluid homeostasis [4]. Pathologically, the receptor is implicated in the progression of various cancers, where it promotes tumor-associated angiogenesis and lymphangiogenesis [6]. It also plays a significant role in the inflammatory response, particularly in sepsis, where its modulation can influence capillary leak and organ failure [5]. Therapeutic interest in AM2 focuses on agonists for treating heart failure and hypertension, as well as antagonists or neutralizing antibodies to inhibit tumor growth and metastasis [7]. Clinical monitoring of this pathway often utilizes mid-regional pro-adrenomedullin (MR-proADM) as a biomarker for disease severity and treatment efficacy [5].
The Adrenomedullin receptor 2 functions through the activation of Gs proteins upon ligand binding, which stimulates adenylyl cyclase to increase intracellular cyclic AMP (cAMP) levels [1, 2]. This signaling cascade activates protein kinase A (PKA) and the PI3K/Akt pathway, leading to the phosphorylation of endothelial nitric oxide synthase (eNOS), resulting in nitric oxide production and vasodilation [3, 7]. Additionally, AM2 signaling stabilizes the endothelial cytoskeleton, thereby enhancing vascular barrier function and reducing capillary leak in inflammatory conditions [5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenomedullin receptor 2 (AM2) (AM2).